CP
SBRA icon

Camelot Portfolios’s Sabra Healthcare REIT SBRA Stock Holding History

Camelot Portfolios’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,354
Closed -$159K – 474
2024
Q2 		$159K Buy
+10,354
New +$148K 0.09% 203
2024
Q1 		– Sell
-10,354
Closed -$148K – 196
2023
Q4 		$148K Buy
+10,354
New +$147K 0.09% 194
2023
Q3 		– Sell
-10,354
Closed -$122K – 187
2023
Q2 		$122K Buy
+10,354
New +$118K 0.08% 182
2022
Q4 		– Sell
-65,152
Closed -$855K – 197
2022
Q3 		$855K Sell
65,152
-30,954
-32% -$457K 0.8% 40
2022
Q2 		$1.34M Buy
96,106
+2,324
+2% +$31.1K 0.81% 36
2022
Q1 		$1.4M Sell
93,782
-12,605
-12% -$172K 0.69% 41
2021
Q4 		$1.44M Buy
106,387
+23,660
+29% +$335K 0.58% 46
2021
Q3 		$1.22M Buy
82,727
+14,415
+21% +$243K 0.62% 47
2021
Q2 		$1.24M Sell
68,312
-4,125
-6% -$73.4K 0.5% 57
2021
Q1 		$1.26M Buy
72,437
+52,102
+256% +$916K 0.52% 56
2020
Q4 		$353K Sell
20,335
-1,650
-8% -$26.3K 0.18% 141
2020
Q3 		$303K Sell
21,985
-2,201
-9% -$32.3K 0.19% 134
2020
Q2 		$349K Sell
24,186
-32,794
-58% -$431K 0.22% 119
2020
Q1 		$622K Sell
56,980
-2,712
-5% -$50K 0.35% 74
2019
Q4 		$1.27M Buy
59,692
+414
+0.7% +$9.27K 0.54% 52
2019
Q3 		$1.36M Sell
59,278
-4,172
-7% -$89K 0.64% 40
2019
Q2 		$1.25M Sell
63,450
-14,669
-19% -$286K 0.52% 62
2019
Q1 		$1.52M Buy
78,119
+7,280
+10% +$138K 0.63% 45
2018
Q4 		$1.17M Sell
70,839
-10,930
-13% -$220K 0.54% 56
2018
Q3 		$1.89M Buy
81,769
+745
+0.9% +$16.9K 0.85% 34
2018
Q2 		$1.76M Buy
81,024
+15,931
+24% +$311K 0.75% 41
2018
Q1 		$1.15M Buy
65,093
+2,237
+4% +$39.4K 0.54% 60
2017
Q4 		$1.18M Sell
62,856
-3,956
-6% -$78.7K 0.56% 54
2017
Q3 		$1.47M Buy
+66,812
New +$1.51M 0.71% 37

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Camelot Portfolios's SBRA Position: Q3 2024 in Review

Camelot Portfolios sold out of Sabra Healthcare REIT (SBRA) in Q3 2024, closing a stake of 10,354 shares — an estimated $159K sold.

Camelot Portfolios first reported a position in SBRA in Q3 2017 and held it in 24 quarters. The position peaked at $1.89M in Q3 2018. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • Camelot Portfolios reported no remaining Sabra Healthcare REIT position as of Q3 2024 after selling out during the quarter.
  • Camelot Portfolios sold 10,354 Sabra Healthcare REIT shares in Q3 2024, an estimated $159K.
  • Camelot Portfolios first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 24 quarters.
  • Camelot Portfolios's Sabra Healthcare REIT position peaked at $1.89M in Q3 2018.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Camelot Portfolios's 13F filing for Q3 2024, filed 12 Nov 2024.